NCT07363005Completed
Parent-Child Mandala Painting During Chemotherapy
Effects of a Parent-Child Mandala Painting Intervention During Chemotherapy on Caregiver Burden, Psychological Well-being, and Child Fear and Pain: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effects of a parent-child mandala painting intervention conducted during the chemotherapy process on caregiver burden, psychological well-being, and child fear and pain levels in pediatric oncology patients. Childhood cancer and its treatment are highly stressful experiences for both children and their parents. Chemotherapy-related side effects such as pain, fear, and emotional distress may negatively affect children's psychological well-being and treatment adaptation. Parents, as primary caregivers, often experience increased emotional burden, anxiety, and stress during this process. The intervention consists of a structured parent-child mandala painting activity delivered over a two-week period, with six sessions in total, each lasting 30 minutes. Participants are randomly assigned to either the intervention group, which receives the mandala painting activity in addition to routine care, or the control group, which receives routine nursing care alone. Outcome measures include child fear and pain levels assessed using validated pediatric scales, as well as caregiver burden and psychological distress measured through standardized questionnaires. Assessments are conducted at baseline and after completion of the two-week intervention period. This study seeks to contribute evidence on the use of creative, non-pharmacological interventions to support emotional well-being in children undergoing chemotherapy and their caregivers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 15 Jan 2026
- Start date
- 22 Nov 2025
- Primary completion date
- 25 Mar 2026
- Lead sponsor
- Yuzuncu Yil University
- Diseases
- Childhood cancers
- NCT number
- NCT07363005
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From 22 Nov 2025 to the primary completion date, 25 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Children diagnosed with stage III or stage IV cancer.
- Presence of visual perception impairments in the child (e.g., color blindness, severe visual impairment).
Other
- Refusal of the child or parent to participate in the study.
Who the study is looking for
- Children aged between 5 and 12 years who are receiving chemotherapy.
- One parent or primary caregiver willing to participate with the child.
- Ability of the child to perform basic fine motor activities such as holding a pencil and coloring.
- Absence of an acute psychiatric diagnosis in the child (e.g., severe anxiety disorder, psychotic disorders).
- Willingness of both the child and the parent to participate in the study.
Age in the registry: 5 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Van Yuzuncu Yil University Dursun Odabas Medical Center Coordinator of this site? Confirm its status | Van | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.